Adrenomedullin Gene Expression and Peptide Levels in the Heart and Blood Vessels of Streptozotocin-diabetic Rats

Abstract

The aim of the present study was to assess the changes in gene expression and peptide adrenomedullin (AM) levels in cardiovascular and other tissues in the streptozotocin-diabetic rats. For this purpose, diabetes was induced by intraperitoneal injection of streptozotocin (STZ, 65 mg/Kg body weight). Half of the diabetic rats were subcutaneously injected with insulin in the afternoon (4 units/day) one week after STZ injection until the day before killing. Control rats received only saline injection. AM mRNA was determined in cardiovascular and other tissues of streptozotocin-diabetic rats using solution-hybridization-RNase protection assay. Circulating AM and peptide AM in cardiovascular and other tissues were estimated using a specific radioimmunoassay. There were increases in preproAM mRNA levels in the left and right ventricles and in the thoracic aorta in both the 2-week and 4-week diabetic rats, but not in the two atria, the mesenteric artery and the lung. In the 2-week diabetic rats, there were decreases in AM contents in the two atria and the lung but an increase in the thoracic aorta. In the 4-week diabetic rats, there were bigger decreases in the atria and also a decrease in the left ventricle. The plasma AM levels were not changed but there was an increase in the excretion of AM in the urine. Our results suggest a possible increase in AM release in the heart and the thoracic aorta in the 2-week and 4-week diabetic rats.

cardiovascular - adrenomedullin - diabetes - heart - blood vessels

References

• 1 Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.  Biochem Biophys Res Commun. 1993;  192 553-560
• 2 Hanna FW, Buchanan KD. Adrenomedullin: a novel cardiovascular regulatory peptide.  QJM. 1996;  89 881-889
• 3 Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin.  Biochem Biophys Res Commun. 1993;  194 720-725
• 4 Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma.  FEBS Lett. 1994;  338 6-10
• 5 Hwang ISS, Tang F. Peripheral distribution and gene expression of adrenomedullin in the rat: possible source of blood adrenomedullin.  Neuropeptides. 2000;  34 32-37
• 6 Isumi Y, Shoji H, Sugo S, Tochimoto T, Yoshioka M, Kangawa K, Matsuo H, Minamino N. Regulation of adrenomedullin production in rat endothelial cells.  Endocrinology. 1998;  139 838-846
• 7 Autelitano DJ, Tang F, Little PJ. Rapid regulation of adrenomedullin in metabolically compromised vascular smooth muscle cells.  J Hypertens. 1999;  17 373-379
• 8 Martinez A, Weaver C, Lopez J, Bhathena SJ, Elsasser TH, Miller MJ, Moody TW, Unsworth EJ, Cuttitta F. Regulation of insulin secretion and blood metabolism by adrenomedullin.  Endocrinology. 1996;  137 2626-2632
• 9 Elhawary AM, Poon J, Pang CC. Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin.  Br J Pharmacol. 1995;  115 1133-1140
• 10 Sato A, Canny BJ, Autelitano DJ. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes.  Biochem Biophys Res Commun. 1997;  230 311-314
• 11 Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic effects of human and rat adrenomedullin in conscious rats.  Br J Pharmacol. 1995;  114 584-591
• 12 Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats.  Eur J Pharmacol. 1993;  241 271-273
• 13 Garcia-Unzueta MT, Montalban C, Pesquera C, Berrazueta JR, Amado JA. Plasma adrenomedullin levels in type 1 diabetes. Relationship with clinical parameters.  Diabetes Care. 1998;  21 999-1003
• 14 Nakamura T, Honda K, Ishikawa S, Kitamura K, Eto T, Saito T. Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus: close relationships with diabetic complications.  Endocr J. 1998;  45 241-246
• 15 Ruzicska E, Toth M, Tulassay Z, Somogyi A. Adrenomedullin and diabetes mellitus.  Diabetes Metab Res Rev. 2001;  17 321-329
• 16 Hebden RA, Gardiner SM, Bennett T, MacDonald IA. The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats.  Clin Sci (Lond). 1986;  70 111-117
• 17 Kuwasako K, Kida O, Kitamura K, Kato J, Eto T. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury.  Int Angiol. 1997;  16 272-279
• 18 Wu SQ, Kwan CY, Tang F. Streptozotocin-induced diabetes has differential effects on atrial natriuretic peptide synthesis in the rat atrium and ventricle: a study by solution-hybridization-RNase protection assay.  Diabetologia. 1998;  41 660-995
• 19 Wu SQ, Tang F. Impaired paracrine effect of endothelin-1 on vascular smooth muscle in streptozotocin-diabetic rats.  Cardiovasc Res. 1998;  39 651-656
• 20 Hwang ISS, Autelitano DJ, Wong PYD, Leung GPH, Tang F. Co-expression of adrenomedullin and adrenomedullin receptors in rat epididymis: distinct physiological actions on anion transport.  Biol Reprod. 2003;  68 2005-2012
• 21 Tang F, Wong RPP. Pituitary contents of beta-endorphin, dynorphin, substance P, cholecystokinin and somatostatin in rats with streptozotocin-induced diabetes.  Biol Signals. 1996;  5 44-50
• 22 Dvorakova MC, Kuncova J, Pfeil U, McGregor GP, Sviglerova J, Slavikova 1 , Kummer W. Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats.  Neuroscience. 2005;  134 51-58
• 23 Kaufman S, Deng Y. Adrenomedullin suppresses atrial natriuretic factor (ANF) secretion from isolated atrium.  Life Sci. 1998;  63 1017-1022
• 24 Hiragushi K, Wada J, Eguchi J, Matsuoka T, Yasuhara A, Hashimoto I, Yamashita T, Hida K, Nakamura Y, Shikata K, Minamino N, Kangawa K, Makino H. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.  Kidney Int. 2004;  65 540-550
• 25 Ebara T, Miura K, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H. Effect of adrenomedulli on renal hemodynamics and functions in dogs.  Eur J Pharmacol. 1994;  263 69-73
• 26 Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. Renal localization and actions of adrenomedullin: a natriuretic peptide.  Am J Physiol. 1995;  268 F657-F663
• 27 Ruzicska E, Foldes G, Lako-Futo Z, Sarman B, Wellmann J, Szenasi G, Tulassay Z, Ruskoaho H, Toth M, Somogyi A. Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.  J Hypertens. 2004;  22 1191-1200
• 28 Nishimori T, Tsujino M, Sato K, Imai T, Marumo F, Hirata Y. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes.  J Mol Cell Cardiol. 1997;  29 2125-2130
• 29 Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H. Evidence for cAMP-independent mechanisms mediating effects of adrenomedullin, a new inotropic peptide.  Circulation. 1998;  97 1062-1070
• 30 Autelitano DJ, Ridings R, Tang F. Adrenomedullin is a regulated modulator of neonatal cardiomyocytes hypertrophy in vitro.  Cardiovasc Res. 2001;  51 255-264
• 31 Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes.  Hypertension. 1998;  31 505-510
• 32 Dobrzynski E, Montanari D, Agata J, Zhu J, Chao J, Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats.  Am J Physiol. 2002;  283 E1291-E1298
• 33 Nagareddy PR, Xia Z, McNeill JH, MacLeod M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.  Am J Physiol. 2005;  289 H2144-H2152
• 34 Hayashi M, Shimosawa 1  T, Fujita T. Hyperglycemia increases vascular adrenomedullin expression.  Biochem Biophys Res Commun. 1999;  258 453-456
• 35 Imai T, Hirata Y, Iwashina M, Marumo F. Hormonal regulation of rat adrenomedullin gene in vasculature.  Endocrinology. 1995;  136 1544-1548
• 36 Minamino N, Shoji 1  H, Sugo S, Kangawa K, Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells.  Biochem Biophys Res Commun. 1995;  211 686-693
• 37 Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus.  Circ Res. 2001;  88 E14-E22
• 38 Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells.  Hypertension. 1995;  25 1185-1190
• 39 Tang F, Wong MPF, Hwang ISS, Li YY. Ether stress increases adrenomedullin gene expression and levels in rat adrenals.  Horm Metab Res. 2005;  37 585-588
• 40 Mazzocchi G, Albertin G, Andreis PG, Neri G, Malendowicz LK, Champion HC, Bahcelioglu M, Kadowitz PJ, Nussdorfer GG. Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland.  Peptides. 1990;  20 1479-1487
• 41 Lang KJD, Kappel A, Goodall GJ. Hypoxia-inducible facator-1a mRNA contains an internal ribosome entry site that allows sufficient translation during normoxia and hypoxia.  Mol Biol Cell. 2002;  13 1792-1801

1 Part of the data was presented at the 4th Symposium on Adrenomedullin and Proadrenomedullin N-20 Peptide held in Zurich in 2004.

Correspondence